At the cellular level, BRAF mutations drive oncogenic behavior of melanoma cells, leading to unrestricted cell growth, increased cell survival, and local invasion through activation of the mitogen-activated protein kinase (MAPK) pathway11. Here, BRAF is linked to melanoma.